RFX8
gene geneOn this page
Also known as FLJ42986
Summary
RFX8 (regulatory factor X8, HGNC:37253) is a protein-coding gene on chromosome 2q11.2, encoding DNA-binding protein RFX8 (Q6ZV50). May be a transcription factor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 731220 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001145664
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37253 |
| Approved symbol | RFX8 |
| Name | regulatory factor X8 |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ42986 |
| Ensembl gene | ENSG00000196460 |
| Ensembl biotype | protein_coding |
| Entrez | 731220 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000428343, ENST00000481179, ENST00000484091, ENST00000492238, ENST00000646446, ENST00000646893, ENST00000939864
RefSeq mRNA: 4 — MANE Select: NM_001145664
NM_001145664, NM_001367508, NM_001367509, NM_001367510
CCDS: CCDS46376
Canonical transcript exons
ENST00000428343 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001471808 | 101421724 | 101421777 |
| ENSE00001756204 | 101414854 | 101414912 |
| ENSE00003480590 | 101405943 | 101406057 |
| ENSE00003518179 | 101402436 | 101402752 |
| ENSE00003559003 | 101410619 | 101410713 |
| ENSE00003581494 | 101412915 | 101413071 |
| ENSE00003605685 | 101422362 | 101422472 |
| ENSE00003676652 | 101418851 | 101418964 |
| ENSE00003679552 | 101466777 | 101466900 |
| ENSE00003694337 | 101417534 | 101417684 |
| ENSE00003844077 | 101474636 | 101475112 |
| ENSE00003850912 | 101397359 | 101397724 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 82.85.
FANTOM5 (CAGE): breadth broad, TPM avg 2.2479 / max 77.3136, expressed in 494 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 29955 | 0.9763 | 359 |
| 29952 | 0.7812 | 329 |
| 29953 | 0.1815 | 100 |
| 29956 | 0.1569 | 78 |
| 29954 | 0.1520 | 66 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.85 | gold quality |
| bone marrow | UBERON:0002371 | 72.16 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 69.60 | gold quality |
| tibial nerve | UBERON:0001323 | 69.58 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 66.82 | gold quality |
| adipose tissue | UBERON:0001013 | 65.62 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 65.24 | gold quality |
| bone marrow cell | CL:0002092 | 65.20 | silver quality |
| islet of Langerhans | UBERON:0000006 | 64.91 | gold quality |
| sural nerve | UBERON:0015488 | 64.34 | gold quality |
| omental fat pad | UBERON:0010414 | 64.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.94 | gold quality |
| testis | UBERON:0000473 | 62.76 | gold quality |
| frontal cortex | UBERON:0001870 | 62.69 | gold quality |
| primary visual cortex | UBERON:0002436 | 62.23 | gold quality |
| left testis | UBERON:0004533 | 62.22 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 62.16 | gold quality |
| right testis | UBERON:0004534 | 62.16 | gold quality |
| placenta | UBERON:0001987 | 61.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.72 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 61.71 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.24 | gold quality |
| skin of abdomen | UBERON:0001416 | 61.03 | gold quality |
| skin of leg | UBERON:0001511 | 60.92 | gold quality |
| zone of skin | UBERON:0000014 | 60.90 | gold quality |
| right frontal lobe | UBERON:0002810 | 60.64 | gold quality |
| cerebral cortex | UBERON:0000956 | 59.99 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.70 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 59.25 | gold quality |
| left uterine tube | UBERON:0001303 | 58.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting RFX8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-187-5P | 99.74 | 70.26 | 1404 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-548V | 99.29 | 69.47 | 1157 |
| HSA-MIR-217-3P | 95.67 | 68.42 | 1000 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rfx8 | ENSMUSG00000057173 |
| rattus_norvegicus | Rfx8 | ENSRNOG00000058243 |
| caenorhabditis_elegans | WBGENE00000914 |
Paralogs (7): RFX3 (ENSG00000080298), RFX2 (ENSG00000087903), RFX4 (ENSG00000111783), RFX1 (ENSG00000132005), RFX5 (ENSG00000143390), RFX7 (ENSG00000181827), RFX6 (ENSG00000185002)
Protein
Protein identifiers
DNA-binding protein RFX8 — Q6ZV50 (reviewed: Q6ZV50)
Alternative names: Regulatory factor X 8
All UniProt accessions (5): A0A2R8Y560, A0A2R8YED2, D6RAX4, E9PDA6, Q6ZV50
UniProt curated annotations — full annotation on UniProt →
Function. May be a transcription factor.
Subcellular location. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the RFX family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZV50-1 | 1 | yes |
| Q6ZV50-2 | 2 | |
| Q6ZV50-3 | 3 |
RefSeq proteins (4): NP_001139136, NP_001354437, NP_001354438, NP_001354439 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003150 | DNA-bd_RFX | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR039779 | RFX-like | Family |
| IPR057321 | RFX1-4/6/8-like_BCD | Domain |
Pfam: PF02257, PF25340
UniProt features (10 total): splice variant 5, sequence conflict 3, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZV50-F1 | 71.29 | 0.30 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
CAGCTG_AP4_Q5, HEN1_01, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, chr2q11, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, S8_01, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MAFG_TARGET_GENES, MIR519E_5P, MIR515_5P, MIR221_3P, MIR222_3P, MIR217_3P, GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP, CEBPGAMMA_Q6
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
438 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RFX8 | RFX7 | Q2KHR2 | 606 |
| RFX8 | RFX5 | P48382 | 557 |
| RFX8 | LENG1 | Q96BZ8 | 553 |
| RFX8 | LLPH | Q9BRT6 | 528 |
| RFX8 | TUSC1 | Q2TAM9 | 486 |
| RFX8 | PDAP1 | Q13442 | 463 |
| RFX8 | KRT85 | P78386 | 462 |
| RFX8 | ACSS3 | Q9H6R3 | 460 |
| RFX8 | LRRTM4 | Q86VH4 | 457 |
| RFX8 | PIGQ | Q9BRB3 | 453 |
| RFX8 | SMIM15 | Q7Z3B0 | 440 |
| RFX8 | THOC1 | Q96FV9 | 438 |
| RFX8 | MSRB3 | Q8IXL7 | 438 |
| RFX8 | FAM228A | Q86W67 | 430 |
| RFX8 | ZMYM3 | Q14202 | 416 |
| RFX8 | OR14C36 | Q8NHC7 | 416 |
IntAct
0 interactions, top by confidence:
BioGRID (1): RFX8 (Affinity Capture-MS)
ESM2 similar proteins: A2BGP7, A2CJ06, A6H5X4, A7E316, E2RSS3, F7BHS0, O35144, O55036, P0DOV1, Q13342, Q1LX29, Q2HJ93, Q3B7D9, Q3TD16, Q3U827, Q5I0E2, Q5I0J8, Q5NBU8, Q5RCZ8, Q5XFX8, Q60953, Q66JT0, Q6AXZ2, Q6AZF8, Q6IE82, Q6IRU7, Q6ZQF7, Q6ZV50, Q7TNY7, Q80VH0, Q8BP86, Q8BVK9, Q8BVM9, Q8C0G2, Q8C0V1, Q8C267, Q8CGE8, Q8K2H3, Q8NDB2, Q91YK2
Diamond homologs: A0A1L8GWK2, A0A1L8H0H2, A0JMF8, A2BGA0, A6QLW9, B1WAV2, B2GV50, D2HNW6, D3YU81, F8VPJ6, P22670, P48377, P48378, P48379, P48380, P48381, P48382, P48383, P48743, Q09555, Q0V9K5, Q2KHR2, Q32NR3, Q33E94, Q4R3I8, Q4R3Z4, Q59V88, Q5EAP5, Q5RDR2, Q5RJA1, Q6ZV50, Q7TNK1, Q8C7R7, Q8HWS3, Q9JL61, Q5AMQ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 9 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2646 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:101452443:CAAG:C | acceptor_gain | 1.0000 |
| 2:101466772:CTTA:C | donor_loss | 1.0000 |
| 2:101466773:TTA:T | donor_loss | 1.0000 |
| 2:101466774:TA:T | donor_loss | 1.0000 |
| 2:101466775:A:AC | donor_gain | 1.0000 |
| 2:101466775:AC:A | donor_gain | 1.0000 |
| 2:101466775:ACCTT:A | donor_gain | 1.0000 |
| 2:101466776:C:CC | donor_gain | 1.0000 |
| 2:101466776:C:CG | donor_loss | 1.0000 |
| 2:101466776:CC:C | donor_gain | 1.0000 |
| 2:101466776:CCTT:C | donor_gain | 1.0000 |
| 2:101466776:CCTTC:C | donor_gain | 1.0000 |
| 2:101466896:CCAAC:C | acceptor_gain | 1.0000 |
| 2:101466897:CAAC:C | acceptor_gain | 1.0000 |
| 2:101466897:CAACC:C | acceptor_gain | 1.0000 |
| 2:101466898:AAC:A | acceptor_gain | 1.0000 |
| 2:101466898:AACCT:A | acceptor_loss | 1.0000 |
| 2:101466899:AC:A | acceptor_gain | 1.0000 |
| 2:101466900:CC:C | acceptor_gain | 1.0000 |
| 2:101466900:CCT:C | acceptor_loss | 1.0000 |
| 2:101466901:CT:C | acceptor_loss | 1.0000 |
| 2:101466902:T:A | acceptor_loss | 1.0000 |
| 2:101474634:ACAC:A | donor_gain | 1.0000 |
| 2:101474635:CA:C | donor_gain | 1.0000 |
| 2:101474635:CACC:C | donor_gain | 1.0000 |
| 2:101474635:CACCT:C | donor_gain | 1.0000 |
| 2:101397721:TGAG:T | acceptor_gain | 0.9900 |
| 2:101397725:C:CC | acceptor_gain | 0.9900 |
| 2:101406069:T:C | acceptor_gain | 0.9900 |
| 2:101406069:T:TC | acceptor_gain | 0.9900 |
AlphaMissense
3139 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000012656 (2:101460689 G>A), RS1000038474 (2:101435113 C>T), RS1000079067 (2:101454935 C>A), RS1000102539 (2:101441396 G>A), RS1000141999 (2:101462442 G>T), RS1000184025 (2:101429372 A>G), RS1000256925 (2:101435363 C>G), RS1000262555 (2:101476337 T>G), RS1000289402 (2:101441172 G>A), RS1000294870 (2:101442591 T>C,G), RS1000314058 (2:101424097 G>T), RS1000330497 (2:101442220 G>A), RS1000371318 (2:101470829 C>T), RS1000380647 (2:101402748 G>A), RS1000407630 (2:101423906 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| bisphenol A | increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Dasatinib | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Calcitriol | decreases expression | 1 |
| Dexamethasone | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.